All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for...

admin
Pr Newswire

Tianjin Advances with AI

admin
Pr Newswire

36Kr Enters into Strategic Partnership with SenseTime to Pioneer AGI Innovation

admin
Pr Newswire

Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®, the...

admin
Pr Newswire

Canadian Solar Inc. Announces Results of 2024 Annual Meeting of Shareholders

admin
Pr Newswire

Goldwind Showcases E-SaaS+ Innovations at The smarter E Europe, Marking Expansion...

admin
Pr Newswire

Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual...

admin
Pr Newswire

Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE...

admin
Pr Newswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

admin
Pr Newswire

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...